Stock Ratings / Health Care / RVP / financials

MODD (36) PAVM (31) PMI (61) NSPR (38) ⌘ Pro Terminal →

Retractable Technologies Inc. (RVP) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

Q: How profitable is Retractable Technologies Inc. (RVP)?

In FY 2025 (10-K), RVP converted $38.3M of revenue into a 0.1% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

$0.58 -1.15% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Retractable Technologies Inc. (RVP) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $17.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-12.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for RVP)Realized 20D OHLCV Swing Band: ±6%

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How RVP Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $43.6M

FY24

Rev $33.0M

FY25

Rev $38.3M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$38.3M	0.1%	-55.3%	-$12.6M	-$7.1M	-23.3%
FY 2024	$33.0M	-3.1%	-63.9%	-$11.9M	-$13.0M	-19.9%
FY 2023	$43.6M	8%	-26.4%	-$7.0M	$2.8M	-23.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring RVP)

✓Walkthrough of RVP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

RVP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -7.94%🛡️ HOLDING TREND SUPPORT

2026-10-30O $0.59H $0.59L $0.57C $0.58VOL 33.3K

RES: $0.74SUP: $0.56SMA50: $0.67SMA200: $0.68

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

RVP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 RVP Butterfly Map → + Track RVP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +15.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on RVP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for RVP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for RVP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RVP)

Health Care Rank #877 of 1016 ⚔️ MODD vs RVP Full Matrix →

1. Head-to-Head Health Care Peer Comparison (RVP vs. MODD, PAVM, PMI, NSPR)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Retractable Technologies Inc. (RVP) ranks #877 by composite RQD confidence (33/100, grade E) and #845 by equity capitalization ($17.3M). Within this direct 5-issuer industry benchmark cohort, RVP leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with RVP at 33/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
RVP ACTIVE Retractable Technologies Inc.	E	33/100	—	0.1%	-23.3%	-1.15%	$17.3M	Benchmark Subject
MODD Modular Medical Inc.	D-	36/100	—	—	-35.0%	-9.95%	$16.3M	/modd-vs-rvp →
PAVM PAVmed Inc.	E	31/100	—	-30.0%	-35.0%	-5.29%	$15.8M	/pavm-vs-rvp →
PMI Picard Medical Inc.	C-	61/100	—	—	—	+12.17%	$19.9M	/pmi-vs-rvp →
NSPR InspireMD Inc.	D-	38/100	—	29.5%	-35.0%	-3.55%	$21.0M	/nspr-vs-rvp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000946563

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Retractable Technologies Inc. (RVP) reported GAAP revenue of $38.3M (+15.8% vs. FY2024 revenue of $33.0M , and -12.2% cumulative change since FY2023) , GAAP net income of -$12.6M, operating cash flow of -$7.1M, and free cash flow of -$7.1M (+45.6% YoY). On the balance sheet, RVP closed FY2025 with $142.6M in total assets against $0 in total debt (Altman Z-Score: 0.52, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$38.3M	-$12.6M	-$7.1M	-$7.1M	$142.6M	—
FY2024 (FY)	2024-12-31	$33.0M	-$11.9M	-$11.6M	-$13.0M	$160.7M	$900.0K
FY2023 (FY)	2023-12-31	$43.6M	-$7.0M	$2.8M	$2.8M	—	—

3. RVP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is RVP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Retractable Technologies Inc. (NYSE: RVP) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $0.58 (-1.15% 1D, market cap $17.3M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, RVP ranks #877 in composite RQD confidence.

How does RVP compare to MODD and PAVM in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), RVP carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 0.1%, and ROIC of -23.3%. By comparison, MODD (Modular Medical Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $16.3M) and PAVM (PAVmed Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $15.8M). Among the 5-stock peer group, RVP leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for RVP?

Per RVP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000946563), Retractable Technologies Inc. generated $38.3M in revenue (+15.8% YoY), -$12.6M in net income, and -$7.1M in free cash flow against $142.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is RVP trading relative to its 50-day, 200-day, and 52-week technical levels?

RVP last traded at $0.58 (-1.15% on volume of 17,484 shares), positioning the stock -13.43% below its 50-day simple moving average ($0.67) and -14.71% below its 200-day simple moving average ($0.68). Across its 52-week range of $0.56 to $0.90, RVP sits at the 5.9% percentile with a 14-day RSI of 22.7 (OVERSOLD (<32)) and an implied next-earnings move of ±6.0% ($1.00 to $0.61).